Egg Allergy Market

By Diagnosis and Treatment;

Diagnosis - Skin Test, Blood Test, Food Challenge and Others, Treatment - Medication, and Oral Immunotherapy.

By Treatment;

Oral Immunotherapy, Medication, and Others

By End User;

Hospitals & Clinics, Diagnostic Centres, and Research Institute.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn283187180 Published Date: August, 2025 Updated Date: September, 2025

Egg Allergy Market Overview

Egg Allergy Market (USD Million)

Egg Allergy Market was valued at USD 2,467.94 million in the year 2024. The size of this market is expected to increase to USD 3,988.97 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.1%.


Egg Allergy Market

*Market size in USD million

CAGR 7.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.1 %
Market Size (2024)USD 2,467.94 Million
Market Size (2031)USD 3,988.97 Million
Market ConcentrationMedium
Report Pages350
2,467.94
2024
3,988.97
2031

Major Players

  • Aimmune Therapeutics
  • DBV Technologies
  • AnaptysBio
  • Genentech
  • Regeneron Pharmaceuticals
  • Sanofi
  • Allergy Therapeutics
  • Allergan
  • Pfizer
  • Novartis

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Egg Allergy Market

Fragmented - Highly competitive market without dominant players


The Egg Allergy Market is expanding rapidly, with over 60% of clinicians combining component diagnostics and oral immunotherapy to enhance treatment outcomes. These approaches focus on personalized risk reduction and support refined patient-focused strategies. Their broader acceptance is fueling consistent growth in allergy care offerings.

Smart Challenge Kits Improving Safety and Data Capture
Around 35% of products now feature standardized dose kits, digital trackers, and reaction logging tools to streamline food challenge protocols. These technological advancements enhance treatment reliability and facilitate remote monitoring. As usage grows, the market’s future outlook is shaped by better-managed and digitally supported therapeutic regimens.

Standardized Protocols Supporting Provider Trust
More than 50% of treatment centers now use certified immunotherapy protocols and comprehensive staff training to secure safe and consistent care delivery. These strategies raise treatment reliability and elevate clinical confidence. The emphasis on official standards is propelling market expansion through robust, credentialed care pathways.

Connected Solutions Driving the Next Phase of Care
Close to 45% of R&D funding is directed at app-enabled dosing systems, wearable allergy monitors, and AI-powered reminders to improve compliance and reaction oversight. These technological advancements offer scalable, personalized support. As smart monitoring evolves, the market is primed for a more intelligent future outlook and ongoing growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Diagnosis and Treatment
    2. Market Snapshot, By Treatment

    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Egg Allergy Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising awareness of allergies
        2. Advances in diagnostic technologies
        3. Increased healthcare expenditure globally
        4. Growing demand for allergy treatments
      2. Restraints
        1. Limited effective treatment options
        2. Lack of standardized diagnostic protocols
        3. Regulatory hurdles in drug development
        4. High cost of allergy management
      3. Opportunities
        1. Emerging markets expansion
        2. Development of innovative therapies
        3. Collaborative research efforts
        4. Personalized medicine approaches
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Egg Allergy Market, By Diagnosis and Treatment, 2021 - 2031 (USD Million)
      1. Diagnosis
        1. Skin Test
        2. Blood Test
        3. Food Challenge
        4. Others
      2. Treatment
        1. Medication
        2. Oral immunotherapy
    2. Egg Allergy Market, By Treatment, 2021 - 2031 (USD Million)

      1. Oral Immunotherapy

      2. Medication

      3. Others

    3. Egg Allergy Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics
      2. Diagnostic Centres
      3. Research Institute
    4. Egg Allergy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Aimmune Therapeutics
      2. DBV Technologies
      3. AnaptysBio
      4. Genentech
      5. Regeneron Pharmaceuticals
      6. Sanofi
      7. Allergy Therapeutics
      8. Allergan
      9. Pfizer
      10. Novartis
  7. Analyst Views
  8. Future Outlook of the Market